| |
| |
|
| Insider
Information: |
Bolzon Bradley J Phd |
| Relationship: |
Director, 10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
21,851 |
|
|
Indirect Shares
|
13,354,534 |
|
|
| Direct
Value |
$113,407 |
|
|
|
Indirect Value
|
$87,225,938 |
|
|
| Total
Shares |
13,376,385 |
|
|
| Total
Value |
$87,339,345 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -15.0%
|
-33.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2006-05-15 |
13,713 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director, 10% Owner |
|
0 |
2014-02-18 |
3,206,807 |
Premium* |
|
|
Phaserx, Inc. |
PZRX |
10% Owner |
|
0 |
2016-05-23 |
1,931,094 |
Premium* |
|
|
Crispr Therapeutics Ag |
CRSP |
Director |
2021-06-29 |
0 |
2021-07-19 |
498,558 |
Premium* |
|
|
Black Diamond Therapeutics, Inc. |
BDTX |
Director, 10% Owner |
2020-12-14 |
21,851 |
2020-12-14 |
5,606,424 |
Premium* |
|
|
Monte Rosa Therapeutics, Inc. |
GLUE |
Director, 10% Owner |
2021-06-28 |
0 |
2021-06-28 |
2,097,938 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
134 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BDTX |
Black Diamond Therapeutic... |
Director |
– • • |
2020-11-23 |
4 |
A |
$0.00 |
$0 |
I/I |
23,599 |
3,316 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2017-12-22 |
4 |
AS |
$20.30 |
$528,237 |
D/D |
(26,016) |
27,724 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • • |
2020-11-10 |
4 |
AS |
$33.48 |
$912,136 |
I/I |
(26,966) |
5,657,523 |
0 |
% |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • • |
2020-10-07 |
4 |
AS |
$33.56 |
$934,079 |
I/I |
(27,836) |
5,756,660 |
0 |
% |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • • |
2020-11-11 |
4 |
A |
$0.00 |
$0 |
I/I |
30,016 |
4,282 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2021-03-22 |
4 |
AS |
$129.36 |
$4,020,667 |
D/D |
(30,374) |
30,375 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-04-30 |
4 |
AS |
$50.26 |
$1,537,138 |
I/I |
(30,566) |
98,736 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • • |
2020-11-30 |
4 |
AS |
$0.00 |
$0 |
I/I |
(32,105) |
0 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2020-12-10 |
4 |
AS |
$140.62 |
$4,730,448 |
I/I |
(33,000) |
314,186 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2020-12-10 |
4/A |
AS |
$140.62 |
$4,730,448 |
D/D |
(33,000) |
7,648 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2020-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
42,272 |
42,272 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-05-15 |
4 |
S |
$57.97 |
$2,551,440 |
I/I |
(44,000) |
640,014 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2021-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
47,536 |
47,536 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2021-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
47,536 |
47,536 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2021-06-29 |
4 |
AS |
$145.92 |
$7,106,341 |
D/D |
(47,536) |
0 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2017-09-05 |
4 |
A |
$0.00 |
$0 |
D/D |
55,447 |
55,447 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2020-09-01 |
4 |
S |
$91.27 |
$5,550,644 |
I/I |
(60,000) |
0 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2020-09-01 |
4 |
OE |
$13.62 |
$1,513,950 |
I/I |
60,000 |
60,000 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
60,068 |
4,012 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
84,544 |
84,544 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-04-20 |
4 |
A |
$0.00 |
$0 |
I/I |
92,918 |
92,918 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-04-23 |
4 |
AS |
$50.66 |
$5,168,901 |
I/I |
(101,994) |
117,173 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2020-10-29 |
4 |
A |
$0.00 |
$0 |
I/I |
105,681 |
105,681 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2018-05-07 |
4 |
AS |
$50.31 |
$6,030,826 |
I/I |
(119,709) |
90,730 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • • |
2020-11-19 |
4 |
AS |
$33.01 |
$4,291,861 |
I/I |
(130,017) |
4,818,600 |
0 |
% |
|
134 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
